.svg){kind=small}
Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has shown a consistent performance in the Arizona market, particularly in the Tincture & Sublingual category, where it maintained a steady third-place ranking from January to April 2026. Despite a decrease in sales from March to April, their position remained unchanged, indicating a strong brand loyalty or market presence. In the Topical category, the brand's performance showed slight fluctuations; it improved its rank from third to second in February and March but slipped back to third in April. This suggests a competitive environment in the Topical category, where Chronic Health is holding its ground but facing pressure from other brands.
Interestingly, the absence of Chronic Health from the top 30 rankings in other states or categories highlights potential areas for growth or challenges in expanding their market reach. The brand's focus seems to be concentrated in Arizona, where it has established a strong foothold. However, the lack of presence in other states or categories could either be a strategic decision to dominate specific segments or a reflection of competitive challenges. Understanding these dynamics could provide insights into Chronic Health's market strategy and potential future movements.
Competitive Landscape
In the competitive landscape of topical cannabis products in Arizona, Chronic Health has demonstrated a strong presence, consistently ranking in the top three from January to April 2026. Despite a slight dip from second to third place in April, Chronic Health's sales have shown resilience, with a notable peak in February. This performance is particularly impressive given the competition from brands like Drip Oils + Extracts, which maintained the top rank throughout the period, and Müv / MUV, which fluctuated but remained a strong contender. Tru Infusion also posed a consistent challenge, holding the third and fourth positions. Interestingly, Gramz made a significant leap from sixth to second place in April, indicating a potential shift in consumer preferences. This dynamic environment suggests that while Chronic Health remains robust, it must continue to innovate and adapt to maintain its competitive edge in the evolving market.
Notable Products
In April 2026, the top-performing product for Chronic Health was the CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz), which rose to the first position with sales of 488 units. This product improved its rank from second place in March. The Indica THC Glycerin Tincture (100mg THC, 1oz) dropped to second place, despite leading the sales in the first three months of the year. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) consistently held the third rank from March to April. Meanwhile, the CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) maintained its fourth position throughout the first four months of the year.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
